August 2021

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF ITS PRIVATE PLACEMENT

First tranche closed represents over three-quarters of the anticipated financing.  VANCOUVER, CANADA, and REHOVOT, ISRAEL, August 30, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) is pleased to announce that it has closed the first tranche (the “First Tranche”) of its non-brokered private placement (the “Private Placement”) previously announced on August 4, 2021. […]

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF ITS PRIVATE PLACEMENT Read More »

BIOHARVEST SCIENCES INC. UNVEILS NEW GROUNDBREAKING CANNABIS TRICHOME STRUCTURE

  New innovative “Amalgamated Trichomes Coral Structure” withstands shear forces applied by the liquid medium New structure acts as a protective shield enabling stable trichome development throughout the growth process Historic scientific milestone validates BioHarvest’s path to commercialization of Cannabis in H1 2022 VANCOUVER, CANADA, and REHOVOT, ISRAEL, August 19th, 2021 – BioHarvest Sciences Inc.’s

BIOHARVEST SCIENCES INC. UNVEILS NEW GROUNDBREAKING CANNABIS TRICHOME STRUCTURE Read More »

BioHarvest Sciences Inc. Announces a CAD 4 Million Private Placement to Accelerate its Cannabis Development Program and Production Capacity in Israel.

VANCOUVER, CANADA, and REHOVOT, ISRAEL, August 4, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) announces that its board of directors has approved a private placement (the “Offering”) for up to 8,888,889 units at a price of CAD 0.45 (the “Offering Price”) per unit for gross proceeds of up to CAD 4,000,000. Each

BioHarvest Sciences Inc. Announces a CAD 4 Million Private Placement to Accelerate its Cannabis Development Program and Production Capacity in Israel. Read More »